RESOURCES AND

RESOURCES AND AS

RESOURCES AND AS OF

RESOURCES AND AS OF TODAY

RESOURCES AND AS OF TODAY CORONAVIRUS

RESOURCES AND AS OF TODAY CORONAVIRUS HAS

RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN

RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO

RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO 18

CORONAVIRUS HAS BEEN TO 18

CORONAVIRUS HAS BEEN TO 18 COUNTRIES.

COUNTRIES.

COUNTRIES. GEORGIA4@

COUNTRIES. GEORGIA4@ IS

COUNTRIES. GEORGIA4@ IS A

COUNTRIES. GEORGIA4@ IS A PART

COUNTRIES. GEORGIA4@ IS A PART OF

COUNTRIES. GEORGIA4@ IS A PART OF THE

COUNTRIES. GEORGIA4@ IS A PART OF THE RACE

COUNTRIES. GEORGIA4@ IS A PART OF THE RACEO

GEORGIA4@ IS A PART OF THE RACEO

GEORGIA4@ IS A PART OF THE RACEO DEVELOP

GEORGIA4@ IS A PART OF THE RACEO DEVELOP A

GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE

GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND

GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND DEKALB

DEVELOP A VACCINE AND DEKALB

DEVELOP A VACCINE AND DEKALB COUNTY

DEVELOP A VACCINE AND DEKALB COUNTY COMPANY

DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES

DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT

DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT HAS

COUNTY COMPANY BELIEVES IT HAS

COUNTY COMPANY BELIEVES IT HAS AN

COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE

COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE

COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT

COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT HAS

AN ADVANTAGE BECAUSE IT HAS

AN ADVANTAGE BECAUSE IT HAS QUITE

AN ADVANTAGE BECAUSE IT HAS QUITE A

AN ADVANTAGE BECAUSE IT HAS QUITE A LONG

AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK

AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK RECORD.

QUITE A LONG TRACK RECORD.

QUITE A LONG TRACK RECORD. >>

QUITE A LONG TRACK RECORD. >> WE

QUITE A LONG TRACK RECORD. >> WE WANTED

QUITE A LONG TRACK RECORD. >> WE WANTED TO

QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN

QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN MORE

>> WE WANTED TO LEARN MORE

>> WE WANTED TO LEARN MORE ABOUT

>> WE WANTED TO LEARN MORE ABOUT THE

>> WE WANTED TO LEARN MORE ABOUT THE PROCESS

>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND

>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE

>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE HENKE

ABOUT THE PROCESS AND JOE HENKE

ABOUT THE PROCESS AND JOE HENKE STOPPED

ABOUT THE PROCESS AND JOE HENKE STOPPED BY

ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR

ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A

ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB

ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB REPORT.

STOPPED BY FOR A LAB REPORT.

STOPPED BY FOR A LAB REPORT. >>

STOPPED BY FOR A LAB REPORT. >> Reporter:

STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY

STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A

STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A RISK

>> Reporter: CURRENTLY A RISK

>> Reporter: CURRENTLY A RISK OF

>> Reporter: CURRENTLY A RISK OF VACCINES

>> Reporter: CURRENTLY A RISK OF VACCINES FOR

>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE

>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS

>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS IS

OF VACCINES FOR THE VIRUS IS

OF VACCINES FOR THE VIRUS IS BEING

OF VACCINES FOR THE VIRUS IS BEING TESTED

OF VACCINES FOR THE VIRUS IS BEING TESTED OR

OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY

OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO

OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO BE

BEING TESTED OR READY TO BE

BEING TESTED OR READY TO BE TESTED

BEING TESTED OR READY TO BE TESTED AND

BEING TESTED OR READY TO BE TESTED AND SOME4@

BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE

BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE VIRUSES

TESTED AND SOME4@ ARE VIRUSES

TESTED AND SOME4@ ARE VIRUSES SIMILAR

TESTED AND SOME4@ ARE VIRUSES SIMILAR TO

TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS

TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS WHICH

SIMILAR TO CORONAVIRUS WHICH

SIMILAR TO CORONAVIRUS WHICH COULD

SIMILAR TO CORONAVIRUS WHICH COULD SPEED

SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP

SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE

SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS

SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS AND

COULD SPEED UP THE PROCESS AND

COULD SPEED UP THE PROCESS AND SOME

COULD SPEED UP THE PROCESS AND SOME WHO

COULD SPEED UP THE PROCESS AND SOME WHO HAS

COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX

COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX EXISTING

SOME WHO HAS SIX EXISTING

SOME WHO HAS SIX EXISTING RELATIONSHIPS

SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH

SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH

SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH 4@

RELATIONSHIPS WITH HEALTH 4@

RELATIONSHIPS WITH HEALTH 4@ OFFICIALS

RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T

RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@

RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@ EITHER

OFFICIALS DOESN'T HURT4@ EITHER

OFFICIALS DOESN'T HURT4@ EITHER >>

OFFICIALS DOESN'T HURT4@ EITHER >> Reporter:

OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS

OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE

OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE RV

>> Reporter: SCIENTISTS LIKE RV

>> Reporter: SCIENTISTS LIKE RV INFECT

>> Reporter: SCIENTISTS LIKE RV INFECT CELLS

>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN

>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES

>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES THEY

INFECT CELLS IN VIRUSES THEY

INFECT CELLS IN VIRUSES THEY ARE

INFECT CELLS IN VIRUSES THEY ARE SETTING

INFECT CELLS IN VIRUSES THEY ARE SETTING AND

INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE

INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE THEIR

ARE SETTING AND USE THEIR

ARE SETTING AND USE THEIR FINDINGS

ARE SETTING AND USE THEIR FINDINGS AS4@

ARE SETTING AND USE THEIR FINDINGS AS4@ THEY

ARE SETTING AND USE THEIR FINDINGS AS4@ THEY DEVELOP

FINDINGS AS4@ THEY DEVELOP

FINDINGS AS4@ THEY DEVELOP VACCINES.

VACCINES.

VACCINES. THEY

VACCINES. THEY USE

VACCINES. THEY USE AN

VACCINES. THEY USE AN APPROACH

VACCINES. THEY USE AN APPROACH THAT

VACCINES. THEY USE AN APPROACH THAT THE

THEY USE AN APPROACH THAT THE

THEY USE AN APPROACH THAT THE CEO

THEY USE AN APPROACH THAT THE CEO SAYS

THEY USE AN APPROACH THAT THE CEO SAYS IT

THEY USE AN APPROACH THAT THE CEO SAYS IT IS

THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT

THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT IN

CEO SAYS IT IS EFFICIENT IN

CEO SAYS IT IS EFFICIENT IN CREATING

CEO SAYS IT IS EFFICIENT IN CREATING A

CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE

CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO

CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE

CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE TESTED

CREATING A VACCINE TO BE TESTED

CREATING A VACCINE TO BE TESTED AND

CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE

CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS

CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT

CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES

CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES A

AND 4@EFFECTIVE AS IT MAKES A

AND 4@EFFECTIVE AS IT MAKES A VACCINE

AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S